Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-803
Closed -$2.35K 1569
2026
Q1
$2.35K Buy
+803
New +$2.29K ﹤0.01% 1353
2018
Q4
Sell
-3,321
Closed -$15K 1158
2018
Q3
$15K Hold
3,321
﹤0.01% 895
2018
Q2
$15K Buy
+3,321
New +$19.5K ﹤0.01% 874

Other funds holding ABEV

Central Trust Company's ABEV Position: Q2 2026 in Review

Central Trust Company sold out of Ambev (ABEV) in Q2 2026, closing a stake of 803 shares — an estimated $2.35K sold.

Central Trust Company first reported a position in ABEV in Q2 2018 and held it in 3 quarters. The position peaked at $15K in Q3 2018. 403 funds tracked by Wall St. Rank hold ABEV as of Q2 2026.

  • Central Trust Company reported no remaining Ambev position as of Q2 2026 after selling out during the quarter.
  • Central Trust Company sold 803 Ambev shares in Q2 2026, an estimated $2.35K.
  • Central Trust Company first reported a position in Ambev in Q2 2018 and held it in 3 quarters.
  • Central Trust Company's Ambev position peaked at $15K in Q3 2018.
  • 403 funds tracked by Wall St. Rank held Ambev as of Q2 2026.

Based on Central Trust Company's 13F filing for Q2 2026, filed 31 Jul 2026.